NASDAQ:TCRR - Tcr2 Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$17.53 -1.38 (-7.30 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$17.53
Today's Range$17.00 - $19.1511
52-Week Range$14.80 - $25.47
Volume50,458 shs
Average Volume80,857 shs
Market Capitalization$406.52 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Tcr2 Therapeutics (NASDAQ:TCRR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Tcr2 Therapeutics in the last 12 months. Their average twelve-month price target is $30.75, suggesting that the stock has a possible upside of 75.41%. The high price target for TCRR is $37.00 and the low price target for TCRR is $27.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyN/AN/AN/A
Consensus Rating Score: 3.00N/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $30.75N/AN/AN/A
Price Target Upside: 75.41% upsideN/AN/AN/A

Tcr2 Therapeutics (NASDAQ:TCRR) Consensus Price Target History

Price Target History for Tcr2 Therapeutics (NASDAQ:TCRR)

Tcr2 Therapeutics (NASDAQ:TCRR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/11/2019Svb LeerinkInitiated CoverageOutperform$27.00HighView Rating Details
3/11/2019WedbushInitiated CoverageOutperform ➝ Outperform$28.00 ➝ $28.00HighView Rating Details
3/11/2019Leerink SwannInitiated CoverageOutperformHighView Rating Details
3/11/2019Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$31.00HighView Rating Details
3/11/2019BMO Capital MarketsInitiated CoverageOutperform$37.00HighView Rating Details
(Data available from 3/23/2017 forward)
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel